 Eperisone has not been established to be safe for use by pregnant women; therefore the drug should only be used in pregnant women, or women who may be pregnant, if the expected therapeutic benefits will outweigh the possible risks associated with treatment.The manufacturers of Myonal recommend the drug not be used during lactation (breast-feeding).If eperisone must be used, the patient is advised to stop breast-feeding for the duration of treatment.